Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...

Twist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Investors in Twist Bioscience Corp (Symbol: TWST) saw new options begin trading this week, for the October 17th expiration. One of the key inputs that goes into the price an option buyer is ...

TD Cowen analyst Brendan Smith maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $58.00. The company’s shares closed yesterday at $39.68.

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat Ratings reports.

Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...